Trial Profile
Compassionate use programme for treatment of late stage lung cancer or lung metastases with QBKPN
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 15 Apr 2015
Price :
$35
*
At a glance
- Drugs QBKPN (Primary)
- Indications Lung cancer
- Focus Expanded access; Therapeutic Use
- Sponsors Qu Biologics